Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Nicotine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116286700B reveals enhanced imine reductase mutants for nicotine synthesis offering superior yield and supply chain reliability for global pharmaceutical manufacturers.
Novel biocatalytic route for nicotine intermediate using engineered imine reductase mutants offering superior conversion and stereoselectivity for industrial scale-up.
Patent CN115404249A reveals a novel enzymatic route for (S)-nicotine intermediates. Discover cost-effective biocatalysis solutions for scalable pharmaceutical manufacturing.